185 related articles for article (PubMed ID: 8914876)
21. Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure.
Tang WH; Vagelos RH; Yee YG; Benedict CR; Willson K; Liss CL; Fowler MB
J Am Coll Cardiol; 2002 Jan; 39(1):70-8. PubMed ID: 11755289
[TBL] [Abstract][Full Text] [Related]
22. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.
McKelvie RS; Yusuf S; Pericak D; Avezum A; Burns RJ; Probstfield J; Tsuyuki RT; White M; Rouleau J; Latini R; Maggioni A; Young J; Pogue J
Circulation; 1999 Sep; 100(10):1056-64. PubMed ID: 10477530
[TBL] [Abstract][Full Text] [Related]
23. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
[TBL] [Abstract][Full Text] [Related]
24. Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure.
Goodfield NE; Newby DE; Ludlam CA; Flapan AD
Circulation; 1999 Jun; 99(23):2983-5. PubMed ID: 10368114
[TBL] [Abstract][Full Text] [Related]
25. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
Shen YT; Wiedmann RT; Greenland BD; Lynch JJ; Grossman W
Cardiovasc Res; 1998 Aug; 39(2):413-22. PubMed ID: 9798526
[TBL] [Abstract][Full Text] [Related]
26. Augmented sympathoinhibitory effect of valsartan when added to angiotensin-converting enzyme inhibitor in patients with left ventricular dysfunction.
Kawamura A; Yuasa F; Yokoe H; Masue Y; Sugiura T; Iwasaka T
J Cardiol; 2009 Apr; 53(2):171-8. PubMed ID: 19304119
[TBL] [Abstract][Full Text] [Related]
27. Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
Shinohara H; Fukuda N; Soeki T; Sakabe K; Onose Y; Tamura Y
Heart Vessels; 2002 Dec; 17(2):47-52. PubMed ID: 12541093
[TBL] [Abstract][Full Text] [Related]
28. Effects of combination of AT1-antagonist candesartan cilexetil and ACE-inhibitors in patients with congestive heart failure.
Gasanin E; Dragutinović I; Banković D; Mitrović V
Srp Arh Celok Lek; 2013; 141(1-2):29-34. PubMed ID: 23539907
[TBL] [Abstract][Full Text] [Related]
29. Renin-angiotensin-aldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: Network meta-analysis.
Xie W; Zheng F; Song X; Zhong B; Yan L
Int J Cardiol; 2016 Feb; 205():65-71. PubMed ID: 26720043
[TBL] [Abstract][Full Text] [Related]
30. ACE inhibitors in heart failure: what more do we need to know?
Demers C; Mody A; Teo KK; McKelvie RS
Am J Cardiovasc Drugs; 2005; 5(6):351-9. PubMed ID: 16259523
[TBL] [Abstract][Full Text] [Related]
31. Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus.
Araki M; Kanda T; Imai S; Suzuki T; Murata K; Kobayashi I
J Cardiovasc Pharmacol; 1995 Jul; 26(1):61-5. PubMed ID: 7564367
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic implications of escape from angiotensin-converting enzyme inhibition in patients with chronic heart failure.
Ennezat PV; Berlowitz M; Sonnenblick EH; Le Jemtel TH
Curr Cardiol Rep; 2000 May; 2(3):258-62. PubMed ID: 10980901
[TBL] [Abstract][Full Text] [Related]
33. Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
Sigurdsson A; Swedberg K
Eur Heart J; 1995 Dec; 16 Suppl N():65-72. PubMed ID: 8682064
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the angiotensin II antagonist UP269-6 with the angiotensin converting enzyme inhibitor enalapril in normotensive volunteers challenged with angiotensin I.
Inglessis N; Nussberger J; Hagmann M; Hiesse-Provost O; Insuasty J; Reid J; Ménard J; Brunner HR
J Cardiovasc Pharmacol; 1995 Jun; 25(6):986-93. PubMed ID: 7564346
[TBL] [Abstract][Full Text] [Related]
35. [Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure].
Vizir VA; Berezin AE
Ter Arkh; 2002; 74(1):52-5. PubMed ID: 11878061
[TBL] [Abstract][Full Text] [Related]
36. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
37. Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study.
Krum H; Massie B; Abraham WT; Dickstein K; Kober L; McMurray JJ; Desai A; Gimpelewicz C; Kandra A; Reimund B; Rattunde H; Armbrecht J;
Eur J Heart Fail; 2011 Jan; 13(1):107-14. PubMed ID: 21169387
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of candesartan, enalapril and their combination in congestive heart failure].
Rapezzi C
Ital Heart J Suppl; 2000 Mar; 1(3):429-30. PubMed ID: 10815278
[No Abstract] [Full Text] [Related]
39. Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) investigators.
Dunselman PH;
Int J Cardiol; 2001 Feb; 77(2-3):131-8; discussion 139-40. PubMed ID: 11182175
[TBL] [Abstract][Full Text] [Related]
40. Importance of angiotensin-converting enzyme inhibitors in myocardial infarction and congestive heart failure: implications for clinical practice.
Pitt B
Cardiology; 1995; 86 Suppl 1():41-5. PubMed ID: 7614506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
